AACR Annual Meeting 2023: Five Things You Need to Know
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
AACR Annual Meeting 2023: Welcoming Global Scholars in Training
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
AACR Annual Meeting 2023: Opening Ceremony Heralds Extraordinary Science
As 21,000 cancer researchers, clinicians, policymakers, and patient advocates thronged the Orange County Convention Center, Margaret Foti, PhD, MD...
AACR Annual Meeting 2023: NFL Star Rodney McLeod and Erika McLeod Partner with AACR in Support of Cancer Research
The American Association for Cancer Research (AACR) was thrilled to welcome Super Bowl Champion Rodney McLeod Jr. and Erika...
AACR Annual Meeting 2023: Closing Plenary Highlights Research Breakthroughs and Next Steps
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
AACR Annual Meeting 2023: A Recap of AACR Blog Posts
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
AACR Annual Meeting 2023: Phase III Immunotherapy Trials Offer Hope for Patients With Lung, Liver, and Biliary Tract Cancers
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
AACR Annual Meeting 2023: NCI Director Shares National Cancer Plan
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
AACR Annual Meeting 2023: The Past, Present, and Future of Targeted Therapies for Pediatric Cancer
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
AACR Annual Meeting 2023: Designing, Targeting, and Delivering Novel Cancer Drugs
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
AACR Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 2, Community Engagement)
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
AACR Annual Meeting 2023: Therapy Advances for Patients With Rare Melanoma Types
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
AACR Annual Meeting 2023: Opening Plenary Covers Breadth of Cancer Research
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
AACR Annual Meeting 2023: The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
AACR Annual Meeting 2023: Demystifying Immune Ecosystems
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
AACR Annual Meeting 2023: Clinical Trials of Therapeutic Cancer Vaccines Show Promise
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
AACR Annual Meeting 2023: Beating KRAS
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
AACR Annual Meeting 2023: Navigating the Challenges of Cancer Treatment During Pregnancy
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
AACR Annual Meeting 2023: Understanding Immune Suppression in Brain Metastases
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Global Scholar-in-Training Program Seeks 2023 Class of Awardees
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
Young Scientists from Around the World Benefit from AACR Support, Attendance at Annual Meeting
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
World Cancer Day: AACR’s Efforts to Close the Care Gap
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Honoring National Cancer Survivors Month, Recognizing the AACR Scientist↔Survivor Program®’s Positive Impact
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 1, Trial Design)
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Driving Progress Against RAS-driven Cancers
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Editors’ Picks: April Highlights from AACR Journals
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Editors’ Picks: May Highlights from the AACR Journals
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
Giving Voice to the Need for Robust Cancer Research Funding
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
25 Years of Trastuzumab: A Legacy of Innovation
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...